Unknown

Dataset Information

0

Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay.


ABSTRACT: Drug resistance in tuberculosis (TB) is a matter of grave concern for TB control programs, as there is currently no cure for some extensively drug-resistant (XDR) strains. There is concern that this resistance could transmit, stressing the need for additional control measures, rapid diagnostic methods, and newer drugs for treatment. We developed an in-house assay that can rapidly detect resistance to drugs involved in the definition of XDR-TB directly from smear-positive specimens. Two hundred fifteen phenotypically XDR-TB isolates and 50 pansusceptible isolates were analyzed using a reverse line blot hybridization (RLBH) assay. The assay was also successfully applied to 73 smear-positive clinical specimens. The RLBH assay exhibited good sensitivity for the detection of resistance to isoniazid (99%), rifampin (99%), fluoroquinolones (95.3%), and second-line aminoglycosides (94.8%). The results from application of this assay on direct smear-positive clinical specimens revealed 93% concordance with the phenotypic drug susceptibility test (DST) results for the above-mentioned drugs. The time to accurate DST results was significantly reduced from weeks to 3 days. This molecular assay is a highly accurate tool for screening for XDR-TB, which achieves a substantial reduction in diagnostic delays.

SUBMITTER: Ajbani K 

PROVIDER: S-EPMC3147869 | biostudies-other | 2011 Jul

REPOSITORIES: biostudies-other

altmetric image

Publications

Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay.

Ajbani Kanchan K   Shetty Anjali A   Mehta Ajita A   Rodrigues Camilla C  

Journal of clinical microbiology 20110525 7


Drug resistance in tuberculosis (TB) is a matter of grave concern for TB control programs, as there is currently no cure for some extensively drug-resistant (XDR) strains. There is concern that this resistance could transmit, stressing the need for additional control measures, rapid diagnostic methods, and newer drugs for treatment. We developed an in-house assay that can rapidly detect resistance to drugs involved in the definition of XDR-TB directly from smear-positive specimens. Two hundred f  ...[more]

Similar Datasets

| S-EPMC2863940 | biostudies-literature
| S-EPMC201233 | biostudies-literature
| S-EPMC2546705 | biostudies-literature
| S-EPMC1448689 | biostudies-literature
| S-EPMC2045312 | biostudies-literature
| S-EPMC1479170 | biostudies-literature
| S-EPMC2738090 | biostudies-literature
| S-EPMC2045372 | biostudies-literature
| S-EPMC87791 | biostudies-literature
| S-EPMC84950 | biostudies-literature